Terns’ Early Data May Position It Well In GLP-1 Obesity Race

 
• By Joseph Haas
  
obesity medication with tape measure
Terns looks competitive in the obesity GLP-1 agonist competition with Phase I data • Source: Shutterstock

More from Clinical Trials

More from R&D